Elagolix
Generic name: Elagolix
Brand names: Orilissa
Dosage form: oral tablet
Drug class:
Gonadotropin-releasing hormone antagonists
Usage of Elagolix
Elagolix belongs to a class of drugs called gonadotropin-releasing hormone (GnRH) receptor antagonist. It is an oral tablet used to help treat pain caused by endometriosis.
Endometriosis is a condition where tissue that should line the uterus or womb, grows outside of the uterus forming lesions. It affects about 1 in 10 women of reproductive age.
During your menstrual cycle these lesions grow in response to rising levels of a hormone called estrogen, then they break down and shed during your period. This can cause pain throughout your cycle.
Elagolix helps to reduce the pain you experience by reducing the amount of estrogen you produce that encourages the lesions to grow. Elagolix works by binding to GnRH receptors in the pituitary gland, which suppresses luteinizing hormone (LH) and follicle-stimulating hormone (FSH) and leads to a decrease in estrogen.
Elagolix side effects
Elagolix can cause serious side effects including:
You or your caregiver should pay attention to any changes, especially sudden changes in your mood, behaviors, thoughts, or feelings.
The most common side effects of elagolix include: hot flashes and night sweats, headache, nausea, difficulty sleeping, absence of periods, anxiety, joint pain, depression and mood changes.
These are not all the possible side effects of elagolix. Call your doctor for medical advice about side effects.
You may report side effects to FDA at 1-800-FDA-1088.
Before taking Elagolix
Relate drugs
- Antagon
- Cetrorelix
- Cetrorelix injectable
- Cetrotide
- Cetrotide injectable
- Elagolix
- Ganirelix
- Ganirelix Acetate
- Orgovyx
- Orilissa
- Relugolix
How to use Elagolix
Two dosing regimens are available:
Warnings
Elagolix may cause serious side effects, including:
What other drugs will affect Elagolix
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Especially tell your healthcare provider if you take:
Know the medicines you take. Keep a list of your medicines with you to show to your healthcare provider and pharmacist when you get a new medicine.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions